The Riverside Company Invests in Alpha-H
April 30, 2019
The Riverside Company has invested in Alpha-H, the Australian skincare maker best known for its Liquid Gold exfoliating treatment, to support the brand's international growth and product development. Riverside will partner with Alpha-H's existing management and shareholders to accelerate distribution across new and existing regions; KPMG M&A advised Alpha-H and Riverside was advised by KPMG, Deloitte and Herbert Smith Freehills.
- Buyers
- The Riverside Company
- Targets
- Alpha-H
- Sellers
- Alpha-H shareholders
- Industry
- Consumer Products
- Location
- Victoria, Australia
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
The Riverside Company Invests in Western Botanicals
February 12, 2026
Food & Beverage
The Riverside Company has made a growth investment in Western Botanicals, a Spanish Fork, Utah-based contract development and manufacturing organization (CDMO) of vitamins, minerals and supplements. Riverside will partner with management — which retains a meaningful ownership stake — to support organic growth, expand product and format capabilities, and pursue an M&A strategy to broaden Western Botanicals' capabilities.
-
The Riverside Company Invests in Apollo Interactive
June 29, 2022
Marketing & Advertising
The Riverside Company’s Strategic Capital Fund made a non-control (growth) investment in Apollo Interactive to help scale the tech-enabled lead generation provider. Riverside plans to support Apollo’s growth — including one or more strategic add-on acquisitions — to deepen product and vertical coverage across insurance and mortgage markets.
-
The Riverside Company Invests in Avance Clinical
November 9, 2021
Healthcare Services
The Riverside Company has invested in Avance Clinical, a leading Australian contract research organisation (CRO), to support the company's regional and international expansion. The investment will help Avance accelerate its clinical trials business — including vaccine and gene-technology studies — with a particular focus on growth in North America and Asia.
-
The Riverside Company Invests in Altius Group Holdings
January 21, 2021
Healthcare Services
The Riverside Company has agreed to make an investment in Altius Group Holdings (Altius), an Australian provider of allied health and workplace rehabilitation services led by founder Derick Borean. Riverside will partner with the Altius team to expand the company's geographic footprint across Australia and broaden its physical and psychological health and wellbeing services to corporate, government and NDIS clients.
-
The Riverside Company Invests in Independent Living Specialists (ILS)
April 6, 2020
Healthcare Services
The Riverside Company has made a growth investment in Independent Living Specialists (ILS), a Sydney-based retailer and distributor of mobility and homecare products. Riverside said the capital will support ILS's national expansion—both organically and via bolt-on acquisitions—and accelerate growth of its retail showrooms, clinically trained field force and online channels.
-
The Riverside Company Invests in HemaTerra Technologies
April 18, 2019
Cloud & SaaS
The Riverside Company has invested in HemaTerra Technologies, a provider of cloud-based SaaS solutions for blood and plasma collection centers, hospitals and related healthcare organizations. Riverside said it will invest in product development, sales and marketing, and strategic partnerships to scale HemaTerra's offerings and support continued growth.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.